|Cornell University, Weill Medical College, M.D|
|Sass & Co.|
|Columbia University, MBA|
|Brown University, B.S.|
Dr. Schiff joined Fund I in September of 1999 and has served as a Managing Partner since 2002. Prior to joining Fund I, Dr. Schiff practiced internal medicine at The New York Presbyterian Hospital where he maintains his position as a Clinical Assistant Professor of Medicine.
Dr. Schiff currently serves as a director of ARMGO Pharma, Inc., Miramar Labs, Inc., Planet Technologies, Inc., SkinMedica, Inc., TransEnterix, Inc. and Zeltiq Aesthetics, Inc. Previously he served as a director of Adams Respiratory Therapeutics, Inc., ArgiNOx Pharmaceuticals, Inc., Barrier Therapeutics, Inc., Bioenvision, Inc., Cempra Pharmaceuticals, Inc., CardioKine, Inc., Dynova Laboratories, Inc., Myogen, Inc. and Sirion Therapeutics, Inc.
Dr. Schiff received his M.D. from Cornell University Medical College, his M.B.A. from Columbia University, and his B.S. with honors in Neuroscience from Brown University.